Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders

Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders

Introduction: Neuromyelitis optica spectrum disorders (NMOSD) are immune-mediated inflammatory disorders of the central nervous system involving astrocytes, B lymphocytes, anti-aquaporin 4, and such inflammatory mediators as interleukin-6. Several immunosuppressants are used in their treatment. Toci...

Full description

Bibliographic Details
Main Authors: E. Carreón Guarnizo, R. Hernández Clares, T. Castillo Triviño, V. Meca Lallana, V. Arocas Casañ, F. Iniesta Martínez, J. Olascoaga Urtaza, J.E. Meca Lallana
Format: Article
Language:English
Published: Elsevier España 2022-04-01
Series:Neurología (English Edition)
Subjects:
Neuromielitis óptica
Espectro de la neuromielitis óptica
Tocilizumab
Tratamiento
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580821000237

Internet

http://www.sciencedirect.com/science/article/pii/S2173580821000237

Similar Items